Revolutionary PRIMA System Restores Vision

In a groundbreaking development in ophthalmology, scientists have introduced the PRIMA system, an artificial eye device designed to restore functional vision to individuals suffering from traditionally untreatable vision loss. This system is the first eye prosthesis that restores usable vision, enabling patients to recognize shapes and patterns, known as shape vision.

How the PRIMA System Works

The PRIMA system consists of two main components: a small camera attached to glasses and a wireless chip implanted in the retina. The camera captures visual information and projects it via infrared light onto the implant, which converts it into electrical signals. These signals replace the damaged photoreceptors that detect light and send visual data to the brain.

This technology is the result of decades of scientific efforts, including numerous prototypes, animal testing, and an initial human trial. The concept of this system was envisioned by Daniel Palanker, a professor of ophthalmology, two decades ago.

Replacing Damaged Photoreceptors

The latest trial involved individuals with advanced age-related macular degeneration, known as geographic atrophy, which gradually destroys central vision. This condition affects over 5 million people worldwide and is the leading cause of irreversible blindness among older adults.

In macular degeneration, the light-receptive cells in the central retina deteriorate, leaving only limited peripheral vision. However, many retinal neurons responsible for processing visual information remain intact, and the PRIMA system leverages these remaining structures.

Integrating Natural and Artificial Vision

The PRIMA system allows patients to use both their natural peripheral vision and the new artificial central vision simultaneously, enhancing their ability to navigate and move. The system operates entirely optically, relying solely on light to generate electrical current, enabling it to function wirelessly and safely under the retina.

The new trial included 38 patients over the age of 60 with geographic atrophy due to age-related macular degeneration and vision worse than 20/320 in at least one eye.

Restoring Reading Ability

Four to five weeks after implanting the chip in one eye, patients began using the glasses. While some patients could distinguish patterns immediately, all patients experienced improved visual acuity over months of training.

Of the 32 patients who completed the year-long trial, 27 were able to read, and 26 showed significant improvement in visual acuity, defined as the ability to read two additional lines on a standard eye chart.

Conclusion

The PRIMA system represents a significant step towards providing innovative solutions for restoring vision to those with untreatable vision loss. Although the current system offers only black-and-white vision, future advancements are expected to enhance visual accuracy and introduce color vision. Research and development continue in this field to address other types of blindness caused by the loss of photoreceptors.